Option Care Health Analyst Ratings
Buy Rating Justified for Option Care Health Amid Revenue Growth and Strategic Adaptability
Analysts Conflicted on These Healthcare Names: HealthStream (HSTM) and Option Care Health (OPCH)
Option Care Health (OPCH) Receives a Buy From Truist Financial
Truist Financial Sticks to Their Buy Rating for Option Care Health (OPCH)
Option Care Health Analyst Ratings
Deutsche Bank Adjusts Option Care Health Price Target to $36 From $35, Maintains Buy Rating
Buy Rating Affirmed for Option Care Health Amidst Strong Q4 Performance and Optimistic FY2024 Guidance
Option Care Health Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Option Care Health (OPCH) and USANA Health (USNA)
Analysts Offer Insights on Healthcare Companies: Option Care Health (OPCH), Alnylam Pharma (ALNY) and Kura Oncology (KURA)
Analysts Offer Insights on Healthcare Companies: Universal Health (UHS), Option Care Health (OPCH) and Bausch + Lomb Corporation (BLCO)
Analysts Offer Insights on Healthcare Companies: Option Care Health (OPCH) and Crispr Therapeutics AG (CRSP)
Barrington Research Maintains Outperform on Option Care Health, Lowers Price Target to $35
Option Care Health Analyst Ratings
Deutsche Bank Cuts Option Care Health Price Target to $35 From $39, Maintains Buy Rating
Analysts Offer Insights on Healthcare Companies: Thermo Fisher (TMO) and Option Care Health (OPCH)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Cytokinetics (CYTK), Medtronic (MDT) and Option Care Health (OPCH)
Option Care Health Analyst Ratings
Option Care Health Receives Buy Rating Amid Promising Q3 Forecasts and Long-Term Growth Projections